… Superiority in Reducing Heart Failure Events After MI (… ) sacubitril-valsartan in patients
post myocardial infarction (MI… use of all available data until trial end, equating a treatment-…

… the efficacy of sacubitril/valsartan over angiotensin-converting enzyme … of heart failure (HF)
in post-MI patients and providing a clear evidence-based medicine guideline for future use. …

… sacubitril/valsartan missed its primary endpoint to reduce the risk of cardiovascular death
and … require a change in treatment, use of prohibited therapies during the study, or cause the …

… The use of diuretics (76%) and digoxin (25%) decreased … the use of newer GDMT (ivabradine,
sacubitril/valsartan, … heart disease did not determine the prevalence of GDMT use. …

… coronary disease and heart failure, sacubitril/valsartan may … sacubitril/valsartan in post-myocardial
infarction patients with … and support the use of sacubitril/valsartan in patients with low …

… dysfunction, resulting in heart failure and death in severe … In a rat model of post-myocardial
infarction, CHOP was … reduced by the LCZ696 and valsartan treatment. Moreover, the …

… Heart failure (HF) remains a significant complication post myocardial infarction (MI) and is …
infarct-related left descending artery and abciximab use in HF+ compared to HF- group. Most …

… receptor blockers in the treatment of heart failure 441 Use of ACE … , HFpEF, and post-myocardial
infarction, respectively. 17, 18, … /valsartan 460 Sacubitril/valsartan in chronic heart failure …

… /valsartan, is recommended for all patients with symptomatic … commonly used spironolactone,
should be added as the … for heart failure, elevated NT-proBNP, post myocardial infarction …

… This drug is recommended for use … post-myocardial infarction ( Table 1 ). Of note, the
PARAGON-HF trial (NCT01920711) compares sacubitril/valsartan and valsartan on cardiovascular …